|
|
Previous Article | Table of Contents | Next Article 
Interleukin-11: a multifunctional growth factor derived from the
hematopoietic microenvironment
XX Du and DA Williams
Herman B Wells Center for Pediatric Research, James Whitcomb Riley Hospital
for Children, Indianapolis, IN.
IL-11 is a unique growth factor derived from cells making up the HM.
Although cloned based on IL-6-like bioactivity, IL-11 and IL-6 have
distinct biologic profiles (Table 1). IL-11, like many recently cloned
growth factors, has pleiotropic effects on hematopoietic cells presumably
depending on the cytokine and cellular environment into which it is
introduced. However, some general findings are consistent (Table 2). In
addition, IL-11 has significant effects, either primary or secondary, on
nonhematopoietic cells, including neurons, small intestine crypt
progenitor/stem cells, and preadipocytes. The institution of human trials
with IL-11 will provide important information on the pharmacologic effects
of IL-11 on human hematopoietic cells in the context of frequently used
chemotherapy protocols. The physiologic role(s) of IL-11 are unknown but
will become clear (at least in the mouse) with gene targeting experiments
underway in several laboratories.
Volume 83,
Issue 8,
pp. 2023-2030,
04/15/1994
Copyright © 1994 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. G. Lee, D. Hartl, H. Matsuura, F. M. Dunlop, P. D. Scotney, L. J. Fabri, A. D. Nash, N.-Y. Chen, C.-Y. Tang, Q. Chen, et al.
Endogenous IL-11 Signaling Is Essential in Th2- and IL-13-Induced Inflammation and Mucus Production
Am. J. Respir. Cell Mol. Biol.,
December 1, 2008;
39(6):
739 - 746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Paiva, L. A. Salamonsen, U. Manuelpillai, C. Walker, A. Tapia, E. M. Wallace, and E. Dimitriadis
Interleukin-11 Promotes Migration, But Not Proliferation, of Human Trophoblast Cells, Implying a Role in Placentation
Endocrinology,
November 1, 2007;
148(11):
5566 - 5572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dimitriadis, C.A. White, R.L. Jones, and L.A. Salamonsen
Cytokines, chemokines and growth factors in endometrium related to implantation
Hum. Reprod. Update,
November 1, 2005;
11(6):
613 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kiessling, G. Muller-Newen, S. N. Leeb, M. Hausmann, H. C. Rath, J. Strater, T. Spottl, K. Schlottmann, J. Grossmann, F. A. Montero-Julian, et al.
Functional Expression of the Interleukin-11 Receptor {alpha}-Chain and Evidence of Antiapoptotic Effects in Human Colonic Epithelial Cells
J. Biol. Chem.,
March 12, 2004;
279(11):
10304 - 10315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Enomoto, T. Furuichi, A. Zanma, K. Yamana, C. Yoshida, S. Sumitani, H. Yamamoto, M. Enomoto-Iwamoto, M. Iwamoto, and T. Komori
Runx2 deficiency in chondrocytes causes adipogenic changes in vitro
J. Cell Sci.,
January 22, 2004;
117(3):
417 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Waxman, K. Mahboubi, R. G. Knickelbein, L. L. Mantell, N. Manzo, J. S. Pober, and J. A. Elias
Interleukin-11 and Interleukin-6 Protect Cultured Human Endothelial Cells from H2O2-Induced Cell Death
Am. J. Respir. Cell Mol. Biol.,
October 1, 2003;
29(4):
513 - 522.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Underhill-Day, L. A. McGovern, N. Karpovich, H. J. Mardon, V. A. Barton, and J. K. Heath
Functional Characterization of W147A: A High-Affinity Interleukin-11 Antagonist
Endocrinology,
August 1, 2003;
144(8):
3406 - 3414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Takeuchi, S. Watanabe, G. Ishii, S. Takeda, K. Nakayama, S. Fukumoto, Y. Kaneta, D. Inoue, T. Matsumoto, K. Harigaya, et al.
Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice
J. Biol. Chem.,
December 6, 2002;
277(50):
49011 - 49018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-F. Chen, C.-Y. Lin, K.-H. Chao, M.-Y. Wu, Y.-S. Yang, and H.-N. Ho
Defective Production of Interleukin-11 by Decidua and Chorionic Villi in Human Anembryonic Pregnancy
J. Clin. Endocrinol. Metab.,
May 1, 2002;
87(5):
2320 - 2328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Gabrilove
Angiogenic Growth Factors: Autocrine and Paracrine Regulation of Survival in Hematologic Malignancies
Oncologist,
October 1, 2001;
6(2008):
4 - 7.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ohata, T. Harada, A. Fujii, S. Yoshida, T. Iwabe, and N. Terakawa
Menstrual cycle-specific inhibition of endometrial stromal cell proliferation by oncostatin M
Mol. Hum. Reprod.,
July 1, 2001;
7(7):
665 - 670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dimitriadis, L.A. Salamonsen, and L. Robb
Expression of interleukin-11 during the human menstrual cycle: coincidence with stromal cell decidualization and relationship to leukaemia inhibitory factor and prolactin
Mol. Hum. Reprod.,
October 1, 2000;
6(10):
907 - 914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Depoortere, T. Thijs, G. Van Assche, J. C. Keith Jr., and T. L. Peeters
Dose-Dependent Effects of Recombinant Human Interleukin-11 on Contractile Properties in Rabbit 2,4,6-Trinitrobenzene Sulfonic Acid Colitis
J. Pharmacol. Exp. Ther.,
September 1, 2000;
294(3):
983 - 990.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Wang, R. J. Homer, L. Hong, L. Cohn, C. G. Lee, S. Jung, and J. A. Elias
IL-11 Selectively Inhibits Aeroallergen-Induced Pulmonary Eosinophilia and Th2 Cytokine Production
J. Immunol.,
August 15, 2000;
165(4):
2222 - 2231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nakayama, T. Hara, M. Hibi, T. Hirano, and A. Miyajima
A Novel Oncostatin M-inducible Gene OIG37 Forms a Gene Family with MyD118 and GADD45 and Negatively Regulates Cell Growth
J. Biol. Chem.,
August 27, 1999;
274(35):
24766 - 24772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Reznikov, A. J. Puren, G. Fantuzzi, G. R. Hamner, U. S. Schwertschlag, J. L. Ryan, and C. A. Dinarello
Suppression of endotoxin-inducible cytokines in whole blood from human subjects following single dose of recombinant human interleukin-11
Innate Immunity,
August 1, 1999;
5(4):
197 - 204.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Opal, J. W. Jhung, J. C. Keith Jr, S. J. Goldman, J. E. Palardy, and N. A. Parejo
Additive Effects of Human Recombinant Interleukin-11 and Granulocyte Colony-Stimulating Factor in Experimental Gram-Negative Sepsis
Blood,
May 15, 1999;
93(10):
3467 - 3472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tanaka, T. Hara, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and A. Miyajima
Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor beta Subunit
Blood,
February 1, 1999;
93(3):
804 - 815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, Z. Zhu, R. Nolfo, and J. A. Elias
Dexamethasone regulation of lung epithelial cell and fibroblast interleukin-11 production
Am J Physiol Lung Cell Mol Physiol,
January 1, 1999;
276(1):
L175 - L185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bruno, S. K. Horrigan, D. Van Den Berg, E. Rozler, P. R. Fitting, S. T. Moss, C. Westbrook, and R. Hoffman
The Smad5 Gene Is Involved in the Intracellular Signaling Pathways That Mediate the Inhibitory Effects of Transforming Growth Factor-beta on Human Hematopoiesis
Blood,
March 15, 1998;
91(6):
1917 - 1923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Tang, L. Yang, Y.-C. Yang, S. X. Leng, and J. A. Elias
Transforming Growth Factor-beta Stimulates Interleukin-11 Transcription via Complex Activating Protein-1-dependent Pathways
J. Biol. Chem.,
March 6, 1998;
273(10):
5506 - 5513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Nandurkar, L. Robb, D. Tarlinton, L. Barnett, F. Kontgen, and C. G. Begley
Adult Mice With Targeted Mutation of the Interleukin-11 Receptor (IL11Ra) Display Normal Hematopoiesis
Blood,
September 15, 1997;
90(6):
2148 - 2159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Barda-Saad, A.-S. Zhang, D. Zipori, and L. A. Rozenszajn
Adhesion of Thymocytes to Bone Marrow Stromal Cells: Regulation by bFGF and IFN-{gamma}
Stem Cells,
May 1, 1997;
15(3):
229 - 236.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Mosley, C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman
Dual Oncostatin M (OSM) Receptors. CLONING AND CHARACTERIZATION OF AN ALTERNATIVE SIGNALING SUBUNIT CONFERRING OSM-SPECIFIC RECEPTOR ACTIVATION
J. Biol. Chem.,
December 20, 1996;
271(51):
32635 - 32643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Usuki, T Tahara, S Iki, M Endo, M Osawa, K Kitazume, T Kato, H Miyazaki, and A Urabe
Serum thrombopoietin level in various hematological diseases
Stem Cells,
September 1, 1996;
14(5):
558 - 565.
[Abstract]
|
 |
|

|
 |

|
 |
 
C. Potten
Protection of the small intestinal clonogenic stem cells from radiation- induced damage by pretreatment with interleukin 11 also increases murine survival time
Stem Cells,
July 1, 1996;
14(4):
452 - 459.
[Abstract]
|
 |
|

|
 |

|
 |
 
L. Robb, D. J. Hilton, T. A. Willson, and C. G. Begley
Structural Analysis of the Gene Encoding the Murine Interleukin-11 Receptor alpha -Chain and a Related Locus
J. Biol. Chem.,
June 7, 1996;
271(23):
13754 - 13761.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|